Abstract. The replicability of an oncolytic virus is measured by its burst size. The burst size is the number of new viruses coming out from a lysis of an infected tumor cell. Some clinical evidences show that the burst size of an oncolytic virus is a defining parameter for the success of virotherapy. This article analyzes a basic mathematical model that includes burst size for oncolytic virotherapy. The analysis of the model shows that there are two threshold values of the burst size: below the first threshold, the tumor always grows to its maximum (carrying capacity) size; while passing this threshold, there is a locally stable positive equilibrium solution appearing through transcritical bifurcation; while at or above the second threshold, there exits one or three families of periodic solutions arising from Hopf bifurcations. The study suggests that the tumor load can drop to a undetectable level either during the oscillation or when the burst size is large enough.
1. Introduction. Oncolytic viruses are genetically altered viruses that can infect and replicate in cancer cells but leave healthy normal cells unharmed. When oncolytic viruses are inoculated into a cancer patient or directly injected into a tumor, they spread throughout the tumor, and infect tumor cells. The viruses that are in the infected tumor cells replicate themselves. Upon a lysis of an infected tumor cell, a swarm of new viruses burst out of the infected cell and infect neighboring tumor cells. Over the last decade, great progress in understanding of the molecular mechanisms of viral cytotoxicity of oncolytic viruses has been providing a fascinating possible alternative therapeutic approach to cancer patients. This alternative approach could be especially beneficial in the case of malignant brain tumor, glioma, since the standard therapy of surgery-radiation-chemotherapy does not typically destroy all the tumor cells; survival rate in high grade glioma is measured in months. Recent experiments in animal brain tumors using genetically engineered viral strains, such as adenovirus, ONYX-15 and CV706, herpes simplex virus 1 and wild-type Newcastle disease virus show these viruses to be relatively non-toxic and tumor specific [4] . Additionally, a wide array of viruses is being tested for potential as oncolytic viruses.
Although oncolytic viruses have shown promising outcomes in some clinical trials [1] , viral oncolytic therapy has not yet lived up to its expectations. One reason is that once inside a cell the oncolytic virus, such as herpes simplex virus type 1 hrR3, replicate poorly; this difficulty may be overcome with advanced technology. Another reason for the failure of efficacy of virotherapy is because of limited understanding of the dynamics that underlie the spread of oncolytic viruses through tumors. Without such an understanding, much of the clinical research is based on trial and error. In this aspect, mathematical modeling can allow us to see the whole spectrum of possible outcomes, and provide the rationale to optimize treatments. Several attempts have been made to understand and characterize viral dynamics by mathematical models [6, 18, 12, 14, 15, 16, 2, 11] . These studies are largely of qualitative simulation in nature and examine how variation in viral and host parameters influences the outcome of treatment. The outcome of virotherapy depends in a complex way on interactions between viruses and tumor cells. A clear picture of the dynamics of virotherapy seems hard to obtain.
Experimental results [10] have shown that a novel glioma-selective HSV-1 mutant (rQNestin34.5) has a high replication ability and doubles the life span of glioma mice. Our work [6] has suggested that viral replication ability is a major factor for the success of virotherapy. Our model in [6] describes interactions among glioma cells, infected glioma cells, viruses, and immune cells. It also includes the immunosuppressive agent, cyclophosphamide. It is a free boundary problem with five nonlinear parabolic partial differential equations. Our study of a space-free virotherapy model [13] suggests that the oscillation is an intrinsic property of virotherapy dynamics and relates to virus replication ability. This paper aims to analyze the dynamics of oncolytic viruses related to replication ability in a relatively simpler setting. We will only consider tumor cells and viruses in a space-free fashion.
This paper is organized as follows. In section 2, we review models of the dynamics of oncolytic viruses in terms of ordinary differential equations, and introduce a common basic model. In section 3, we mathematically analyze our basic model. In section 4, using published data, we demonstrate the typical dynamic behaviors of our basic model by numerical simulation, and give a brief discussion and several open problems of virotherapy dynamics.
2. Mathematical models. Within the framework of modeling interacting populations by systems of ordinary differential equations, Wodarz and Komarova [16] proposed a general model (1) based on the law of mass action,
where x stands for the uninfected tumor cell population and y the infected tumor cell population. The function F describes the growth properties of the uninfected tumor cells, and the function G describes the rate at which tumor cells become infected by the virus. These two functions could take several different forms, depending on how much detail of the biology is incorporated into the model. The coefficient β represents the infectivity of the virus. The infected tumor cells die with a rate ay. This is a basic framework to describe the dynamics of virotherapy. From our study [6, 8] , the free virus population itself is very important for virotherapy dynamics.
Actually, Wodarz [17] proposed a three population model (2),
Here, v stands for the free virus population. The tumor growth is modeled by logistic growth, and C is maximal tumor size. The term αy models the release of virions by infected tumor cells, and γv is the clearance rate of free virus particles by various causes including non-specific binding and generation of defective interfering particles. The death rate of tumor cells dx seems redundant, since it is included in the logistic model. Dingli et al [5] proposed a similar model by replacing the first equation in (2) by a generalized logistic model,
Here, ε is a constant. In order to consider the recombinant effect of measles virus, Dingli et al [2] proposed the following model (4)
where ρxy describes cell-cell fusion effect during the virotherapy. This model includes an important fact that tumor cells and free virus both decrease due to infection. In our PDE model [6] and ODE model [13] , we model virus replication ability by its burst size. The burst size of a virus is the number of new viruses released from a lysis of an infected cell. Different types of viruses have different burst sizes. Viruses of the same type have almost the same burst size. The burst size is an important parameter of virus replicability. Including the burst size b, we propose a common basic model for virotherapy:
Since tumor cells infected by most types of viruses do not combine each other [4] , we do not include recombinant effect into this basic model. Logistic growth is a common growth pattern. We therefore take it as uninfected tumor growth instead of a generalized one.
3.
Analysis of the basic model. The main results can be summarized as follows.
Theorem 3.1. The system (5) has three equilibria, E 0 = (0, 0, 0), E 1 = (1, 0, 0), and the positive equilibrium E * . E 0 is always unstable for all positive values of b. E 1 is globally asymptotically stable when 0 < b < b s1 , and it is unstable when b ≥ b s1 . At b = b s1 , the positive equilibrium E * moves into the domain D, a type of transcritical bifurcation occurs with E 1 and E * . As b increases, while b s1 < b < b s2 and b ∈ I p , E * is locally asymptotically stable; when b > b 0 and b ∈ I n , E * is unstable. Hopf bifurcations occur for some b ≥ b s2 , and these bifurcations give rise to one or three families of periodic solutions. As b becomes large enough,
). We will use Lyapunov functions, center manifold theorem to study equilibria. To study Hopf bifurcations, we will develop new properties of coefficient parameterized polynomials and properties of Routh-Hurwitz determinants since the bifurcation values are not algebraically expressible. Since the bust size is a measure of capability of a virus, the main results have the following possible biological implications. When viruses are not powerful, the burst size is less than b s1 , virotherapy fails. When viruses are powerful but not very powerful, the burst size is in the range b s1 < b < b s2 , virotherapy can be partially successful. When viruses are very powerful, virotherapy successes in the sense of tumor load dropping to a undetectable level.
In the rest of this section, we shall present preliminary results, equilibrium analysis, and Hopf bifurcation analysis. We will also highlight biological implications of mathematical statements when available. 
For convenience, dropping all bars over the variables and write τ as t, we have
It is assumed that all parameters are nonnegative.
Proof. If the conclusion x(t) ≥ 0, y(t) ≥ 0, and v(t) ≥ 0 for t ≥ 0 is not true, there must be a time t 1 , such that there is at least one component that will be zero first. We check each possible case.
If x(t 1 ) = 0 first, then x (t 1 ) = 0. From the first equation of (6) , by the uniqueness of the solution we know x(t) = 0 for all t ≥ t 1 . Then the second equation of (6) becomes y (t) = −y. Its solution is y(t) = y(t 1 )e t1−t . So, y(t) ≥ 0 since y(t 1 ) > 0. The third equation becomes v (t) = by − cv. Its solution is v(t) = v(t 1 )e −c(t−t1) + be −c(t−t1) t t1 e cτ y(τ )dτ . Therefore, v(t) ≥ 0. If y(t 1 ) = 0 first, then y (t 1 ) = ax(t 1 )v(t 1 ) ≥ 0. So, y(t) ≥ 0 when t ≥ t 1 since x(t) > 0 and v(t) > 0 as assumed.
If v(t 1 ) = 0 first, then v (t 1 ) = by(t 1 ) ≥ 0. So, after t 1 , v(t) ≥ 0 since x(t) > 0 and y(t) > 0 as assumed.
If two components are zero simultaneously at t 1 , it is easy to check that the third component will be nonnegative when t > t 1 .
If the three components are zero simultaneously at t 1 , then from the uniqueness of the solution, x(t) = 0, y(t) = 0, and v(t) = 0 for t ≥ 0.
Therefore, x(t) ≥ 0, y(t) ≥ 0, and v(t) ≥ 0 for t ≥ 0.
Since the initial value of each component is nonnegative, the solution is nonnegative. So,
Proof. Under the given conditions, the solution components x(t) and y(t) are both nonnegative and smaller than 1. v (t) = by − axv − cv ≤ by − cv ≤ b − cv, by the comparison theorem, v(t) ≤ 
The variational matrix of the system (6) is given by
At the equilibrium point E 0 , the variational matrix is
eigenvalues are r, -1, and -c. Since r is positive, E 0 is unstable. For the linearization of the system (6) at E 0 , the stable invariant subspace is the y-v plane, and the unstable invariant subspace is the x axis. It happens that for the system (6), the local stable invariant manifold is in the y-v plane, and the unstable invariant manifold is in the x axis. A possible interpretation is that without viruses and infected tumor cells the tumor will grow from an initial small value around E 0 . If all tumor cells are infected, then the tumor will shrink until it disappears into E 0 .
At the equilibrium point E 1 , the variational matrix is
The eigenvalues are λ 1 = −r and λ 2,3 =
Proof. At the equilibrium E 1 , the eigenvalue λ 1 = −r and λ 2 = 
Actually, we can prove that the equilibrium solution E 1 is globally asymptotically stable when b < 1 + c a . Here by the word "globally", we mean the whole positive invariant domain D. We will construct two Lyapunov functions according to different ranges of the parameter b. For convenience, we make a translation of variables, x = 1 − x, y = y, and v = v. After dropping the bars over variables, the system becomes
while the domain D is translated to
Proof. For any initial condition (x 0 , y 0 , v 0 ) in the Domain D 1 , we know from Lemma 3.2 and Lemma 3.3, the solution satisfies 0 ≤ x(t) ≤ 1, 0 ≤ y(t) ≤ 1 and v(t) ≥ 0. We will construct two Lyapunov functions according to the values of the parameter b to prove y(t) and v(t) approach 0, and then prove x(t) also approaches 0.
It is obvious that V 1 (x, y, v) > 0, and the orbital derivativeV 1 (x, y, v) = y +v = (b−1)y−cv < 0.
It is easy to see V 2 (x, y, v) > 0. The derivative along a solution is given bẏ
, that is, ab − a − c < 0 and 1 − b < 0, hence,V 2 (x, y, v) < 0. Therefore, combining these two Lyapunov functions, we have y(t) → 0 and v(t) → 0 as t → +∞ when b < 1 + c a . Considering the component x(t), we see that
where k is the initial value for x(t). The limit ke −rt → 0 as t → +∞, while the limit Thus, x(t) → 0 as t → +∞. Such, (x(t), y(t), v(t)) approaches the origin wherever the initial value is in D 1 . Therefore, the original system (6) has a global attractor E 1 . Theorem 3.5 has an important biological implication. When the burst size of the oncolytic virus is smaller than 1 + c a , the virotherapy always fails. This failure is determined by the replication ability of the oncolytic virus, and it does matter what the initial tumor size, the initial infected portion of the tumor, and the initial amount of injected virus are as long as they are in the domain D. The burst size does not depends on initial conditions. The number 1 + c a is a threshold value for the burst size. We denote it by b s1 as the first threshold. Namely, b s1 = 1 + c a . Consider the critical case b = b s1 . It implies ab = a + c. In this case, the linearized system at E 1 has two negative eigenvalues and one zero eigenvalue. In order to determine the stability of the equilibrium solution E 1 , we will use the center manifold theorem to reduce the system (7) into a center manifold, and study the reduced system. We state the result first. Proof. To reduce the system (7) to a center manifold, we first standardize the system, separate it into two parts, the part with zero eigenvalue and the part with negative eigenvalues. The system (7) does not have complex eigenvalues in this case. We start with the matrix corresponding to the linear part of the system (7),
It has eigenvalues, −r, −(1 + ab) and 0.
The eigenvalue −r has an associated eigenvector
T , 0 has an associated eigenvector V 3 = (ar + a, ar, r)
T . We set a transformation matrix to be
T . Then the system (7) can be written as
where
T , then we have
=A 11 y , where A ij , B ij and C ij are coefficients that can be easily determined.
Then the transformed system can be written as
where B = −r 0 0 −(1 + ab)
, A = (0), and Z = (y 1 , y 2 ).
It is easy to check that A has zero eigenvalue, B has negative eigenvalues, f 1 , f 2 and f 3 are C 2 differentiable functions, f k (0, 0, 0) = 0 and Df k (0, 0, 0) = 0, k = 1, 2, 3, where Df is the first derivative of the function f . Then from the Center Manifold Theorem [3] , there is a center manifold given by Z = h(
, and it satisfies
It is known that h(0) = 0 and h (0) = 0. So, we assume that h 1 (u)
For simplicity, we only consider the order up to 5, and we will know it is enough late. Then, ). Now we reduce the system (7) to its center manifold, which is a single equation
and is
It is easy to see that y 3 = 0 is a node regardless of the sign of 
The characteristic polynomial is given by
, a 2 = . By the Routh-Hurwitz Criterion [7] , all roots of the polynomial (11) have negative real parts if and only if
When b > b s1 , we have ab − a − c > 0. So, H 1 = a 1 > 0, and a 3 > 0. Since H 3 = H 2 a 3 , we only need to consider H 2 . We thus get the following theorem.
Theorem 3.7. When ϕ(b) < r − a, the equilibrium solution E * is locally asymptotically stable.
We will refine this theorem in the next subsection, and explain its biological implication. We define a function Φ(x) by
It is easy to see that
When b = 1 and b = 1 − For the function Φ(x), there are three different cases: Φ(x) has four distinct real roots, or three distinct real roots (one repeated), or two real roots and two conjugate complex roots. We will check each case.
If Φ(x) has four distinct real roots, then there will be three roots or one root that are greater than c a . Figure 1 shows the case where three roots are greater than c a . We take the greatest root to be x 0 , then x 0 > c a and Φ (x 0 ) < 0 since the polynomial Φ(x) is decreasing around x 0 . Actually Φ(x) is decreasing to −∞ as x goes to +∞ from any point that is slightly bigger than x 0 .
Figure 1. Φ(x) has four roots
If Φ(x) has three distinct real roots, then there is one repeated root. Figure 2 shows cases that Φ(x) has three or two roots. We can not choose this repeated root since the graph of Φ(x) is tangent to the x−axis at the point of the repeated root. Hence Φ(x) does not change sign around the point of the repeated root, and is not monotonic around this point. If the repeated root is in the between of these roots, x 1 and x 2 , we choose the greater one as x 0 . If the repeated root is the smallest one, we choose the greatest root to be x 0 . If the repeated root is the greatest root, we choose the middle one to be x 0 . We claim that the middle root is bigger than If Φ(x) has only two distinct real roots, we take the greater one to be x 0 . It is also true that Φ (x 0 ) < 0.
As we choose x 0 for all cases, x 0 > c a , Φ(x 0 ) = 0 and Φ (x 0 ) < 0. Since
we then have
We rename the variable x as b, and set b 0 = 1 + x 0 . Then, H (b 0 ) < 0. Since H (b) is continuous, so there exists a positive number δ 1 that can be made smaller
is monotonic in this interval. Since the tumor load at the equilibrium point E * is less than 1, this equilibrium point represents a partial success of virotherapy at a modest value of the burst size. Although we are not able to prove it is globally asymptotically stable (this is one open problem), it is locally asymptotically stable. This also implies that a permanent reduction of tumor load can be reached. Lemma 3.10. A cubic polynomial λ 3 + a 1 λ 2 + a 2 λ + a 3 = 0 with real coefficients has a pair of pure imaginary roots if and only if a 2 > 0 and a 3 = a 1 a 2 . When it has pure imaginary roots, the pure imaginary roots are given by ±i √ a 2 , the real root is given by −a 1 , and a 1 a 3 > 0.
Proof. Suppose the cubic polynomial has a pair of complex roots λ = u ± vi and one real root λ = λ 0 . Then,
We compute,
We compare coefficients, and have
a1+2u , and
It is easy to conclude that u = 0 if and only if a 2 > 0 and a 3 − a 1 a 2 = 0. If u = 0, we see that v 2 = a 2 and λ 0 = −a 1 . Since (u 2 + v 2 )(a 1 + 2u) = a 3 becomes v 2 a 1 = a 3 , a 1 and a 3 have the same sign.
Lemma 3.11. Consider a coefficient parameterized polynomial λ 3 + a 1 (τ )λ 2 + a 2 (τ )λ + a 3 (τ ) = 0, where coefficients a k (τ ), k = 1, 2, 3, are all continuously differentiable real-valued functions. Denote its roots by λ(τ ) = α(τ ) + iβ(τ ), where α(τ ) is the real part and β(τ ) is the imaginary part. Suppose there is a value τ 0 , such that α(τ 0 ) = 0 and β(τ 0 ) = 0, i.e. λ(τ 0 ) = iβ(τ 0 ). If
Proof. For the complex roots of a cubical polynomial, there are formulae to compute
It is easy to see that λ(τ ) is a differentiable function of the parameter τ , and λ (τ ) = α (τ ) + iβ (τ ).
Differentiating the given polynomial with respect to the parameter τ , we have that 3λ
2 λ + a 1 λ 2 + 2a 1 λλ + a 2 λ + a 2 λ + a 3 = 0. Evaluate the left-hand side of this expression at τ = τ 0 and notice that α(τ 0 ) = 0. If α (τ 0 ) = 0, we have −3iβ
Separate the real part and the imaginary part, we have
Solve these two equations for β (τ 0 ), we get β (τ 0 ) =
respectively. Therefore,
. That is,
From the proofs of Lemma 3.8, Lemma 3.10 and Lemma 3.11 and Routh-Hurwitz Criterion, we have the following corollary for the characteristic polynomial (11) . We consider each coefficient of p(λ) to be a function of the parameter b. Actually,
, a 2 (b) = If α (b 0 ) = 0, then from Lemma 3.11, we have a
. We evaluate
This is a contradiction, since H (b 0 ) = 0 from Lemma 3.8. Hence, α (b 0 ) = 0.
Since the exact value of b 0 is not algebraically expressible, the stability, amplitudes, and periods of periodical solutions that occur around b 0 and E * are difficult to analyze. We will simulate the system in the next section to demonstrate some typical dynamics. Here, we simply state a corollary about Hopf bifurcation [9] .
Corollary 2. If the equilibrium solution E
* is stable, but not asymptotically stable at b = b 0 , then all solutions of the system (6) in a neighborhood of E * are periodical (in a surface). If the equilibrium solution E * is asymptotically stable or unstable at b = b 0 , then there is an asymptotically stable periodical solution in a neighborhood of E * when b is close to b 0 .
It is clear that for all cases in Figure 2 , we only can have one Hopf bifurcation at b 0 = 1 + x 0 . However, for the case in Figure 1 , we can have three Hopf bifurcations at b = 1 + x 0 , b = 1 + x 2 and b = 1 + x 3 . There will be three families of periodic solutions rising from these bifurcation. The similar bifurcation analysis can be done for the parameter values b = 1 + x 2 and b = 1 + x 3 . The only downside is that we can not study their nature sine we don't have explicit algebraic expressions for these values.
From the proof of Theorem 3.12, when the burst size b is big enough, there is at least one root of the characteristic polynomial (14) with positive real part. Actually, there exists b = b g > b 0 such that for every b > b g , the characteristic polynomial (14) has a root with positive real part. Therefore, E * is unstable for any large burst size. However, the tumor load at this equilibrium T (E * ) = x + y can be made as small as possible by increasing the burst size b. We state this in the following theorem.
Theorem 3.13. At the equilibrium solution E * , the tumor load T (E * ) is a decreasing function of the burst size b, and
Proof. From Theorem 3.9, we have T (E * ) = undetectable tumor, we then consider the tumor is eradicated. The minimum of the pulsating oscillation solution is decreasing as the burst size b increases. We can make it even smaller by increasing b.
4.2.
Discussion. In this article we presented the analysis of a common basic model for virotherapy. It highlights key values of the burst size of a virus in oncolytic virus treatment. There are two threshold values for the burst size. When the burst size is smaller than the first threshold value, virotherapy always fails. When the burst size is in the between of the two threshold values, we have a partial success of virotherapy represented by the stable positive equilibrium solution. Since the tumor load is a decreasing function of the burst size, the minimum tumor load can be reached by genetically increasing the burst size of the virus up to the second threshold value. If the set in which the positive equilibrium solution is stable has more than one open intervals, we can increase the burst size up to the supreme value of this set, and still have stable partial therapeutic success with even lower tumor load. Once the burst size is greater than the second threshold value, there are one or three families of stable periodic solutions to the system of virotherapy dynamics. This indicates that there is a predator-prey type interaction among three populations, an oscillation among uninfected tumor cells, infected tumor cells, and virus. As the burst size continues to increase, the periodic solution becomes pulsating oscillation. The minimum tumor load can be small enough such that it is beyond the detectable level.
If we express the first threshold by original parameters, we have b s1 = γ βK . It is clear that the first threshold value of the burst size is determined by a combination of the infectivity of the virus, the clearance rate of the virus, and the maximum tumor size. In other words, besides the selectivity of a virus, the burst size of an oncolytic virus and the maximum tumor size will determine the outcome of the virotherapy. This is biologically meaningful. The bigger the tumor is, the more powerful viruses are required to fight it. To further understand the dynamics of oncolytic viruses and improve the efficacy of virotherapy, a thorough understanding of the basic process of viral treatments is needed. We propose some open questions regarding the basic dynamics of virotherapy here. One open problem is how to compute these manifolds.
When b > b s1 and close to b s1 , the equilibrium solution E * is locally asymptotically stable while E 1 is unstable. If the initial value is in the unstable manifold of E 1 , does the solution converge to E * ? When b s1 < b < b s2 , or b ∈ I p , is the positive equilibrium solution E * globally stable? If this is indeed the case, the permanent partial reduction of tumor load can be reached no matter what the initial conditions are.
What conditions can guarantee that the function H(b) has four, three, and two distinct real zeros? Then we can specify when one or three families of periodic solutions arise from Hopf bifurcations.
When b is very big, say b > b g , all three equilibrium solutions are unstable. Does a pulsating periodic solution still arise from a Hopf bifurcation in this case?
It is interesting to study bifurcations with two parameters, the burst size and the virus clearance, or the burst size and the maximum tumor size. This will have important biological implications.
